A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2011
10/06/2011	US20110245248 Isoquinoline derivatives
10/06/2011	US20110245235 Systems, Methods, and Devices for Rehabilitation of Auditory System Disorders Using Pharmaceutical Agents and Auditory Devices
10/06/2011	US20110245227 Pyridone gpr119 g protein-coupled receptor agonists
10/06/2011	US20110245225 Quinazolinamide derivatives
10/06/2011	US20110245223 Heterocyclic compounds
10/06/2011	US20110245214 Organic compounds
10/06/2011	US20110245195 Method of reducing intraocular pressure in humans
10/06/2011	US20110245194 Adenosine compounds and their use thereof
10/06/2011	US20110245193 Combination compositions for reducing intraocular pressure
10/06/2011	US20110245190 Method for improving post surgery visual acuity outcome with azithromycin
10/06/2011	US20110245189 Composition and method for the treatment of eye disease
10/06/2011	US20110245180 Modified Peptide that reduces pain in peripheral neuropathy
10/06/2011	US20110245177 Method for topical treatment of eye disease and composition and device for said treatment
10/06/2011	US20110245175 INHIBITING INTERACTION BETWEEN THE HIF-1ALPHA AND p300/CBP WITH HYDROGEN BOND SURROGATE-BASED
10/06/2011	US20110245169 Protection, restoration and enhancement of erythropoietin responsive cells, tissues and organs
10/06/2011	US20110244064 composition for the treatment of hypertension
10/06/2011	US20110244052 Polyunsaturated fatty acids for improving vision
10/06/2011	US20110244010 Medical devices including medicaments and methods of making and using same
10/06/2011	US20110243999 Methods and compositions for the treatment of ocular disorders
10/06/2011	US20110243955 Antibody and uses thereof
10/06/2011	US20110243936 TNFalpha-NEUTRALIZING ANTIBODIES
10/06/2011	US20110243924 Novel methods
10/06/2011	US20110243884 Biodegradable polymer - bioactive moiety conjugates
10/06/2011	CA2794332A1 Anti-cd40 antibodies
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2370077A2 Method for treating macular degeneration
10/05/2011	EP2369926A1 Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues
10/05/2011	EP1501830B1 7-aryl-3,9-diazabicyclo[3.3.1]non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
10/05/2011	EP1377276B1 Timed pulse release composition
10/05/2011	CN102209548A Compositions comprising polymers having amino sugar units and methods of making and using same
10/05/2011	CN102205132A Preparation formula of gene therapy medicament taking recombinant adeno-associated virus (rAAV) as vector
10/05/2011	CN102205110A Application of integrin blocker in preparation of medicaments for treating ocular neovascular diseases
10/05/2011	CN102205057A Preparation method of traditional Chinese medicine for treating conjunctival congestion type infant influenza
10/05/2011	CN102204938A Medicament for external use for treating otitis media
10/05/2011	CN102204931A Amiotide eye drop containing composite bacteriostatic agent
10/05/2011	CN102204930A Improved modalities for the treatment of degenerative diseases of the retina
10/05/2011	CN102204928A Application of regenerative cells to promoting wound healing
10/05/2011	CN102204903A Application of peperomin E and peperomin B compounds to medicament for suppressing angiogenesis
10/05/2011	CN102204894A Iodized lecithin enteric capsule preparation and preparation method thereof
10/05/2011	CN102204766A Health-care Chinese medicinal pillow for deafness
10/05/2011	CN101716133B Aseculin ophthalmic gel and production method and application thereof
10/05/2011	CN101130058B Emulsion of cyclosporin A for eyes and method of producing the same
10/04/2011	US8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
10/04/2011	US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides
10/04/2011	CA2494536C A 12-membered ring macrolide active substance
10/04/2011	CA2491079C Therapeutic piperazine derivatives useful for treating pain
10/04/2011	CA2438520C Phthalazinone-piperidino-derivatives as pde4 inhibitors
09/2011
09/29/2011	WO2011119969A1 Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof
09/29/2011	WO2011119919A1 Adenosine compounds and their use thereof
09/29/2011	WO2011119174A1 Treating allergy with detoxified e. coli heat-labile enterotoxin
09/29/2011	WO2011119008A2 Peptides for promoting angiogenesis and an use thereof
09/29/2011	WO2011118795A1 Composition for treatment of damaged part
09/29/2011	WO2011117568A1 Compounds targeting the vegf and/or hif pathway such as sorafenib or vatalanib for use in the treatment of otitis media
09/29/2011	WO2011053801A3 Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye
09/29/2011	US20110238075 Drug delivery devices and methods
09/29/2011	US20110238036 Sustained release delivery devices
09/29/2011	US20110237659 Chromenone derivatives as trpv3 antagonists
09/29/2011	US20110237651 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
09/29/2011	US20110237650 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
09/29/2011	US20110237648 Rna interference in skin indications
09/29/2011	US20110237622 Renin inhibitors
09/29/2011	US20110237617 Thieno[2,3-c] isoquinolines for use as inhibitors of parp
09/29/2011	US20110237605 Molecular Crystal of (4-(1,8-Naphthyridin-2-YL)Piperidin-1-YL)Pyrimidine Derivative
09/29/2011	US20110237599 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/29/2011	US20110237596 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
09/29/2011	US20110237592 Substituted amido phenoxybenzamides
09/29/2011	US20110237586 Biaryl compositions and methods for modulating a kinase cascade
09/29/2011	US20110237583 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer
09/29/2011	US20110237574 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
09/29/2011	US20110237573 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
09/29/2011	US20110237565 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/29/2011	US20110237561 Organic compounds
09/29/2011	US20110237555 Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea
09/29/2011	US20110237548 Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome using omega choline
09/29/2011	US20110237543 Composition for Prevention or Treatment of Eye Diseases
09/29/2011	US20110237527 Sglt-2 inhibitors, methods of making them, and uses thereof
09/29/2011	US20110237511 EP4 Receptor Agonist, Compositions and Methods Thereof
09/29/2011	US20110236994 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
09/29/2011	US20110236464 Membrane
09/29/2011	US20110236457 Micronized Device for the Delivery of Biologically Active Molecules and Methods of Use Thereof
09/29/2011	US20110236454 Injectable drug delivery formulation
09/29/2011	US20110236439 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
09/29/2011	US20110236395 Treatment of fibrotic eye disorders using an mmp2 inhibitor
09/29/2011	US20110236352 PEGylation by the Dock and Lock (DNL) Technique
09/29/2011	CA2794187A1 Rna interference in ocular indications
09/29/2011	CA2794153A1 Chemical compounds
09/29/2011	CA2793643A1 Compounds targeting the vegf and/or hif pathway such as sorafenib or vatalanib for use in the treatment of otitis media
09/29/2011	CA2792266A1 Method of reducing intraocular pressure in humans using n6-cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof
09/29/2011	CA2792265A1 Adenosine compounds and their use thereof
09/28/2011	EP2368898A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
09/28/2011	EP2368557A1 Methods of simultaneously treating ocular rosacea and acne rosacea
09/28/2011	EP2367564A1 Norrin in the treatment of diseases associated with an increased tgf-beta activity
09/28/2011	EP1463531B1 Methods for inhibiting ocular processes
09/28/2011	EP1237891B1 Heterocyclic dihydropyrimidines as potassium channel inhibitors
09/28/2011	CN1344159B Combinations for treatment of diseases involving angiogenesis
09/28/2011	CN102203058A Sulfur-linked compounds for treating opthalmic diseases and disorders
09/28/2011	CN102202519A Method for producing lipid
09/28/2011	CN102199587A Functional mutant of human plasminogen, its preparation method and application
09/28/2011	CN102199150A Optical active oxazolidinone derivatives as well as preparation methods and application to preparing medicaments
09/28/2011	CN102199123A New crystal form and pharmaceutical application of fasudil

1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 531